Novel crystal form of 1-(8-bromopyrido [2, 3-e] [1, 2, 4] triazolo [4, 3-a] pyrazine-4-yl)-n-methylazetidine-3-amine hemisuccinate

The present invention relates to a novel crystalline form of 1-(8-bromopyrido [2, 3-e] [1, 2, 4] triazolo [4, 3-a] pyrazin-4-yl)-N-methylazetidine-3-amine hemisuccinate, as well as a pharmaceutical composition comprising the same. The invention also provides the use of the novel polymorph for the tr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: NIELSEN KIM TROENSEGAARD, LARSEN FLEMMING HOEJLUND
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator NIELSEN KIM TROENSEGAARD
LARSEN FLEMMING HOEJLUND
description The present invention relates to a novel crystalline form of 1-(8-bromopyrido [2, 3-e] [1, 2, 4] triazolo [4, 3-a] pyrazin-4-yl)-N-methylazetidine-3-amine hemisuccinate, as well as a pharmaceutical composition comprising the same. The invention also provides the use of the novel polymorph for the treatment of diseases, such as atopic dermatitis (AD), pruritus, pruritus and various forms of urticaria, such as the chronic idiopathic urticaria subtype. 本发明涉及1-(8-溴吡啶并[2,3-e][1,2,4]三唑并[4,3-a]吡嗪-4-基)-N-甲基氮杂环丁烷-3-胺半琥珀酸盐的新晶型,以及包含它的药物组合物。本发明还提供了该新多晶型用于治疗疾病,如特应性皮炎(AD)、瘙痒、瘙痒症和各种形式的荨麻疹,例如慢性特发性荨麻疹亚型的用途。
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN117642403A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN117642403A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN117642403A3</originalsourceid><addsrcrecordid>eNqNir0KwjAURrs4iPoO102hAdsGdZWiOHVyK6XE9JYG8lOSKKSjT24KPoDT-fjOWSafyrxRArfBeSahN1aB6SEjuzN5WqPMGKzoDNR5CgXBBuoshbhpA94KNhkZHZ0dayC2bBIaCSVB7okmCv0QJJvQi27-Y6UiYUAl3ItzoZnHdbLomXS4-XGVbG_XR3knOJoW3cg4avRtWWXZ6UhzeiguxT_NF7vKRT8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Novel crystal form of 1-(8-bromopyrido [2, 3-e] [1, 2, 4] triazolo [4, 3-a] pyrazine-4-yl)-n-methylazetidine-3-amine hemisuccinate</title><source>esp@cenet</source><creator>NIELSEN KIM TROENSEGAARD ; LARSEN FLEMMING HOEJLUND</creator><creatorcontrib>NIELSEN KIM TROENSEGAARD ; LARSEN FLEMMING HOEJLUND</creatorcontrib><description>The present invention relates to a novel crystalline form of 1-(8-bromopyrido [2, 3-e] [1, 2, 4] triazolo [4, 3-a] pyrazin-4-yl)-N-methylazetidine-3-amine hemisuccinate, as well as a pharmaceutical composition comprising the same. The invention also provides the use of the novel polymorph for the treatment of diseases, such as atopic dermatitis (AD), pruritus, pruritus and various forms of urticaria, such as the chronic idiopathic urticaria subtype. 本发明涉及1-(8-溴吡啶并[2,3-e][1,2,4]三唑并[4,3-a]吡嗪-4-基)-N-甲基氮杂环丁烷-3-胺半琥珀酸盐的新晶型,以及包含它的药物组合物。本发明还提供了该新多晶型用于治疗疾病,如特应性皮炎(AD)、瘙痒、瘙痒症和各种形式的荨麻疹,例如慢性特发性荨麻疹亚型的用途。</description><language>chi ; eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240301&amp;DB=EPODOC&amp;CC=CN&amp;NR=117642403A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240301&amp;DB=EPODOC&amp;CC=CN&amp;NR=117642403A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NIELSEN KIM TROENSEGAARD</creatorcontrib><creatorcontrib>LARSEN FLEMMING HOEJLUND</creatorcontrib><title>Novel crystal form of 1-(8-bromopyrido [2, 3-e] [1, 2, 4] triazolo [4, 3-a] pyrazine-4-yl)-n-methylazetidine-3-amine hemisuccinate</title><description>The present invention relates to a novel crystalline form of 1-(8-bromopyrido [2, 3-e] [1, 2, 4] triazolo [4, 3-a] pyrazin-4-yl)-N-methylazetidine-3-amine hemisuccinate, as well as a pharmaceutical composition comprising the same. The invention also provides the use of the novel polymorph for the treatment of diseases, such as atopic dermatitis (AD), pruritus, pruritus and various forms of urticaria, such as the chronic idiopathic urticaria subtype. 本发明涉及1-(8-溴吡啶并[2,3-e][1,2,4]三唑并[4,3-a]吡嗪-4-基)-N-甲基氮杂环丁烷-3-胺半琥珀酸盐的新晶型,以及包含它的药物组合物。本发明还提供了该新多晶型用于治疗疾病,如特应性皮炎(AD)、瘙痒、瘙痒症和各种形式的荨麻疹,例如慢性特发性荨麻疹亚型的用途。</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNir0KwjAURrs4iPoO102hAdsGdZWiOHVyK6XE9JYG8lOSKKSjT24KPoDT-fjOWSafyrxRArfBeSahN1aB6SEjuzN5WqPMGKzoDNR5CgXBBuoshbhpA94KNhkZHZ0dayC2bBIaCSVB7okmCv0QJJvQi27-Y6UiYUAl3ItzoZnHdbLomXS4-XGVbG_XR3knOJoW3cg4avRtWWXZ6UhzeiguxT_NF7vKRT8</recordid><startdate>20240301</startdate><enddate>20240301</enddate><creator>NIELSEN KIM TROENSEGAARD</creator><creator>LARSEN FLEMMING HOEJLUND</creator><scope>EVB</scope></search><sort><creationdate>20240301</creationdate><title>Novel crystal form of 1-(8-bromopyrido [2, 3-e] [1, 2, 4] triazolo [4, 3-a] pyrazine-4-yl)-n-methylazetidine-3-amine hemisuccinate</title><author>NIELSEN KIM TROENSEGAARD ; LARSEN FLEMMING HOEJLUND</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN117642403A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2024</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>NIELSEN KIM TROENSEGAARD</creatorcontrib><creatorcontrib>LARSEN FLEMMING HOEJLUND</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NIELSEN KIM TROENSEGAARD</au><au>LARSEN FLEMMING HOEJLUND</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Novel crystal form of 1-(8-bromopyrido [2, 3-e] [1, 2, 4] triazolo [4, 3-a] pyrazine-4-yl)-n-methylazetidine-3-amine hemisuccinate</title><date>2024-03-01</date><risdate>2024</risdate><abstract>The present invention relates to a novel crystalline form of 1-(8-bromopyrido [2, 3-e] [1, 2, 4] triazolo [4, 3-a] pyrazin-4-yl)-N-methylazetidine-3-amine hemisuccinate, as well as a pharmaceutical composition comprising the same. The invention also provides the use of the novel polymorph for the treatment of diseases, such as atopic dermatitis (AD), pruritus, pruritus and various forms of urticaria, such as the chronic idiopathic urticaria subtype. 本发明涉及1-(8-溴吡啶并[2,3-e][1,2,4]三唑并[4,3-a]吡嗪-4-基)-N-甲基氮杂环丁烷-3-胺半琥珀酸盐的新晶型,以及包含它的药物组合物。本发明还提供了该新多晶型用于治疗疾病,如特应性皮炎(AD)、瘙痒、瘙痒症和各种形式的荨麻疹,例如慢性特发性荨麻疹亚型的用途。</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN117642403A
source esp@cenet
subjects ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Novel crystal form of 1-(8-bromopyrido [2, 3-e] [1, 2, 4] triazolo [4, 3-a] pyrazine-4-yl)-n-methylazetidine-3-amine hemisuccinate
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T05%3A34%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NIELSEN%20KIM%20TROENSEGAARD&rft.date=2024-03-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN117642403A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true